These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 19451620)

  • 1. The gray aspects of white matter disease in multiple sclerosis.
    Steinman L
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8083-4. PubMed ID: 19451620
    [No Abstract]   [Full Text] [Related]  

  • 2. Gray-matter injury in multiple sclerosis.
    Rudick RA; Trapp BD
    N Engl J Med; 2009 Oct; 361(15):1505-6. PubMed ID: 19812410
    [No Abstract]   [Full Text] [Related]  

  • 3. Contactin-2/TAG-1-directed autoimmunity is identified in multiple sclerosis patients and mediates gray matter pathology in animals.
    Derfuss T; Parikh K; Velhin S; Braun M; Mathey E; Krumbholz M; Kümpfel T; Moldenhauer A; Rader C; Sonderegger P; Pöllmann W; Tiefenthaller C; Bauer J; Lassmann H; Wekerle H; Karagogeos D; Hohlfeld R; Linington C; Meinl E
    Proc Natl Acad Sci U S A; 2009 May; 106(20):8302-7. PubMed ID: 19416878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cortical pathology in multiple sclerosis.
    Stadelmann C; Albert M; Wegner C; Brück W
    Curr Opin Neurol; 2008 Jun; 21(3):229-34. PubMed ID: 18451703
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Medicine: Collateral damage repaired.
    Steinman L
    Nature; 2003 Apr; 422(6933):671-2. PubMed ID: 12700743
    [No Abstract]   [Full Text] [Related]  

  • 6. High field (9.4 Tesla) magnetic resonance imaging of cortical grey matter lesions in multiple sclerosis.
    Schmierer K; Parkes HG; So PW; An SF; Brandner S; Ordidge RJ; Yousry TA; Miller DH
    Brain; 2010 Mar; 133(Pt 3):858-67. PubMed ID: 20123726
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Progression of gray matter atrophy and its association with white matter lesions in relapsing-remitting multiple sclerosis.
    Bendfeldt K; Kappos L; Radue EW; Borgwardt SJ
    J Neurol Sci; 2009 Oct; 285(1-2):268-9; author reply 269. PubMed ID: 19500803
    [No Abstract]   [Full Text] [Related]  

  • 8. Inflammatory disease: assault on the guardian.
    Ransohoff RM
    Nature; 2007 Jul; 448(7152):421-2. PubMed ID: 17653181
    [No Abstract]   [Full Text] [Related]  

  • 9. Complement activation in autoimmune demyelination: dual role in neuroinflammation and neuroprotection.
    Rus H; Cudrici C; Niculescu F; Shin ML
    J Neuroimmunol; 2006 Nov; 180(1-2):9-16. PubMed ID: 16905199
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regionally distinct white matter lesions do not contribute to regional gray matter atrophy in patients with multiple sclerosis.
    Antulov R; Carone DA; Bruce J; Yella V; Dwyer MG; Tjoa CW; Benedict RH; Zivadinov R
    J Neuroimaging; 2011 Jul; 21(3):210-8. PubMed ID: 20412395
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Multiple sclerosis: a white matter disease with associated gray matter damage.
    Filippi M
    J Neurol Sci; 2001 Mar; 185(1):3-4. PubMed ID: 11266683
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple sclerosis: serum-induced demyelination in vitro. A light and electron microscope study.
    Raine CS; Hummelgard A; Swanson E; Bornstein MB
    J Neurol Sci; 1973 Oct; 20(2):127-48. PubMed ID: 4750873
    [No Abstract]   [Full Text] [Related]  

  • 13. Neuronal degeneration in a viral model of multiple sclerosis.
    Schneider R
    J Neurosci; 2009 Dec; 29(49):15353-4. PubMed ID: 20007459
    [No Abstract]   [Full Text] [Related]  

  • 14. Loss of retinal nerve fibre layer axons indicates white but not grey matter damage in early multiple sclerosis.
    Young KL; Brandt AU; Petzold A; Reitz LY; Lintze F; Paul F; Martin R; Schippling S
    Eur J Neurol; 2013 May; 20(5):803-11. PubMed ID: 23369013
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The astrocytic response in early experimental autoimmune encephalomyelitis occurs across both the grey and white matter compartments.
    Pham H; Ramp AA; Klonis N; Ng SW; Klopstein A; Ayers MM; Orian JM
    J Neuroimmunol; 2009 Mar; 208(1-2):30-9. PubMed ID: 19195719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural trait markers of bipolar disorder: disruption of white matter integrity and localized gray matter abnormalities in anterior fronto-limbic regions.
    Bora E; Pantelis C
    Biol Psychiatry; 2011 Feb; 69(4):299-300. PubMed ID: 21272736
    [No Abstract]   [Full Text] [Related]  

  • 17. Diagnostic criteria in multiple sclerosis: headed in the right direction but still a ways to go.
    Rudick RA
    Ann Neurol; 2011 Feb; 69(2):234-6. PubMed ID: 21387367
    [No Abstract]   [Full Text] [Related]  

  • 18. Longitudinal spatiotemporal distribution of gray and white matter pathology in multiple sclerosis.
    Bendfeldt K; Kappos L; Radue EW; Borgwardt S
    AJNR Am J Neuroradiol; 2010 May; 31(5):E45; author reply E46. PubMed ID: 20223882
    [No Abstract]   [Full Text] [Related]  

  • 19. Myelin peptides in multiple sclerosis.
    Grau-López L; Raïch D; Ramo-Tello C; Naranjo-Gómez M; Dàvalos A; Pujol-Borrell R; Borràs FE; Martínez-Cáceres E
    Autoimmun Rev; 2009 Jul; 8(8):650-3. PubMed ID: 19393199
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alpha-B-crystallin induces an immune-regulatory and antiviral microglial response in preactive multiple sclerosis lesions.
    Bsibsi M; Holtman IR; Gerritsen WH; Eggen BJ; Boddeke E; van der Valk P; van Noort JM; Amor S
    J Neuropathol Exp Neurol; 2013 Oct; 72(10):970-9. PubMed ID: 24042199
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.